Trailing-twelve-month (TTM) revenue is $4.72 Billion with a year-over-year growth of +4.58%. Revenue represents the total income generated from the company's primary business operations.
Trailing-12-month revenue adds these four fiscal quarters. Amounts are in USD, rounded only to whole currency units.
| Fiscal period | Revenue | Source |
|---|---|---|
| Q3 FY2025Period ended 2025-09-28 | $1,125,500,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2025-10-28 |
| Q4 FY2025Period ended 2025-12-28 | $1,177,100,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-02-20 |
| Q1 FY2026Period ended 2026-03-29 | $1,151,500,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-04-30 |
| Q2 FY2026Period ended 2026-06-28 | $1,261,100,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-08-06 |
| TTM revenue | $4,715,200,000 |
Current P/S: $27,126,226,775 market capitalization ÷ $4,715,200,000 TTM revenue = 5.75x.
Market capitalization source: FMP quote. Quote observed 2026-09-11T20:00:03.000Z. Latest revenue period ended 2026-06-28.
Current market capitalization comes from the quote provider. EPS weighted-average shares are a separate measure.
These references are supplied through FMP. Full filing context identifiers and dimensional metadata are unavailable in the normalized feed.
Reported quarterly revenue; no daily interpolation. Q2 FY2026 (2026-06-28): $1.26B.
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters Quote observation: 2026-09-12T00:15:12.625Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-09-10.
Selected amounts supplied by FMP for each displayed period. Reviewed label references appear where available; other labels are unverified, and items may overlap.
2025-12-28 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
2025-12-28 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20202020-12-31 · USD | FY20212021-12-31 · USD | FY20222022-12-31 · USD | FY20232023-12-31 · USD | FY20242024-12-29 · USD | FY20252025-12-28 · USD |
|---|---|---|---|---|---|---|
| Advanced Alloys & Solutions | $1.9B | $1.8B | $2.4B | $2.3B | $2.4B | $2.3B |
| High Performance Materials & Components | $1.2B | $1.2B | $1.8B |
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20202020-12-31 · USD | FY20212021-12-31 · USD | FY20222022-12-31 · USD | FY20232023-12-31 · USD | FY20242024-12-29 · USD | FY20252025-12-28 · USD |
|---|---|---|---|---|---|---|
| CANADA | N/A | $76M | $87M | N/A | $116M | $170M |
| CHINA | $316M | $370M | $352M | $333M |
$4.72B
$4.72 Billion
+4.58%
vs. $4.51B a year ago (TTM)
+11.07%
5 Year compound annual growth rate
1 Year
+4.58%
3 Year
+4.88%
5 Year
+11.07%
10 Year
+3.39%
15 Year
+0.49%
20 Year
+1.20%
CAGR shows the annualized growth rate over the specified period, smoothing out year-to-year volatility.
| Year | Revenue | YoY Change | % Change |
|---|---|---|---|
| 2025 | $4.59B | +$225.30M | +5.16% |
| 2024 | $4.36B | +$188.40M | +4.51% |
| 2023 | $4.17B | +$337.70M | +8.80% |
| 2022 | $3.84B | +$1.04B | +37.01% |
| 2021 | $2.80B | ($182.30M) | (6.11%) |
| 2020 |
TTM Growth
+4.58%
3-Year CAGR
+4.88%
5-Year CAGR
+11.07%
Revenue growth vs the same fiscal quarter in the prior fiscal year, last 40 comparable quarters.
Current FMP quote-based enterprise value / four-quarter revenue Quote observation: 2026-09-12T00:15:12.625Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-09-10.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
| $2.3B |
| $2.5B |
| $2.7B |
| $300M |
| $324M |
| FRANCE | $85M | N/A | $157M | $219M | $228M | $246M |
|---|
| GERMANY | $125M | $121M | $201M | $243M | $260M | $227M |
|---|
| JAPAN | $86M | N/A | N/A | N/A | N/A | N/A |
|---|
| Rest Of World | $434M | $466M | $602M | $740M | $676M | $703M |
|---|
| UNITED KINGDOM | N/A | $154M | $218M | $259M | $258M | $277M |
|---|
| UNITED STATES | $1.8B | $1.5B | $2.2B | $2.3B | $2.5B | $2.6B |
|---|
| $2.98B |
| ($1.14B) |
| (27.66%) |
| 2019 | $4.12B | +$75.90M | +1.88% |
| 2018 | $4.05B | +$521.50M | +14.79% |
| 2017 | $3.53B | +$390.50M | +12.46% |
| 2016 | $3.13B | ($585.00M) | (15.73%) |
